Emulsions with alkyl polyglucosides as carriers for off-label topical spironolactone – safety and stability evaluation

References

• Afzali BM, Yaghoobi E, Yaghoobi R, Bagherani N, Dabbagh MA. 2012. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatol Treat. 23(1):21–25.
   PubMed Web of Science ®Google Scholar
• Archer JS, Chang RJ. 2004. Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 18(5):737–754.
   PubMed Web of Science ®Google Scholar
• Attwa EM, Ibrahim ASM, El-Halim MFA, Mahmoud HM. 2019. Efficacy and safety of topical spironolactone 5% gel versus placebo in the treatment of acne vulgaris. Egypt J Dermatol Venerol. 39(2):89–94.
   Google Scholar
• Berardesca E, Gabba P, Ucci G, Borroni G, Rabbiosi G. 1988. Topical spironolactone inhibits dihydrotes testosterone receptors in humans sebaceous glands: an autoradio graphic study in subjects with acne vulgaris. Int J Tissue React. 10:115–119.
   PubMedGoogle Scholar
• Califano L, Cannavo S, Siragusa M, Girardi R. 1990. Experience in the therapy of acne with topical administration on spironolactone as an antiandrogen. Clin Ter. 135(3):193–199.
   PubMedGoogle Scholar
• Chen W, Zouboulis CC, Fritsch M, Kodelja V, Orfanos CE. 1998. Heterogeneity and quantitative differences of type 1 5 alpha-reductase expression in cultured skin epithelial cells. Dermatology. 196(1):51–52.
   PubMed Web of Science ®Google Scholar
• Chiu H-Y, Tsai T-F. 2011. Topical use of systemic drugs in dermatology: a comprehensive review. J Am Acad Dermatol. 65(5):1048.e1–e22.
   Web of Science ®Google Scholar
• Chularojanamontri L, Tuchinda P, Kulthanan K, Pongparit K. 2014. Moisturizers for acne: what are their constituents? J Clin Aesthet Dermatol. 7(5):36–44.
   PubMedGoogle Scholar
• Eccleston GM. 1997. Formulating cosmetic emulsions: advances in understanding emulsion technology. Cosmet Toilet. 112(12):65–71.
   Google Scholar
• Feily A, Taheri T, Meier-Schiesser B, Rhinehart DP, Sobhanian S, Colon-Diaz M, Feily A, Ramirez-Fort MK. 2019. The effect of low-dose isotretinoin therapy on serum androgen levels in women with acne vulgaris. Int J Womens Dermatol. 6(2):102–104.
   PubMedGoogle Scholar
• Grimes D, Lyssikatos J. 2018. Human dermal safety testing for topical drug products. FDA Workshop: Sep 10; [accessed 2020 Jan 9]. https://www.fda.gov/media/124984/download.
   Google Scholar
• Gupta M, Vyas SP. 2012. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 165(4):454–461.
   PubMed Web of Science ®Google Scholar
• Henze C, Hinney B, Wuttke W. 1998. Incidence of increased androgen levels in patients suffering from acne. Dermatology. 196(1):53–54.
   PubMed Web of Science ®Google Scholar
• Holmberg K. 2001. Natural surfactants. Cur. Opin. Colloid Interf. Sci. 6(2):148–159.
   Web of Science ®Google Scholar
• Ilic D, Cvetkovic M, Blazevic-Kamenov N, Tasic-Kostov M. Topical spironolactone in a natural non-ionic emulsifier based vehicle – a safety assessment, 2019. Skin and Formulation, 5th Symposium & 17th Skin Forum, Book of Abstracts, p. 57.
   Google Scholar
• Jaksic I, Lukic M, Malenovic A, Reichl S, Hoffmann C, Müller-Goymann C, Daniels R, Savic S. 2012. Compounding of a topical drug with prospective natural surfactant-stabilized pharmaceutical bases: physicochemical and in vitro/in vivo characterization-a ketoprofen case study. Eur J Pharm Biopharm. 80(1):164–175.
   PubMed Web of Science ®Google Scholar
• James WD, Berger TG, Elston DM. 2000. Andrews’ Diseases of the skin, clinical dermatology (9th ed. Philadelphia: Saunders.
   Google Scholar
• Ju Q, Tao T, Hu T, Karadağ AS, Al-Khuzaei S, Chen W. 2017. Sex hormones and acne. Clin Dermatol. 35(2):130–137.
   PubMed Web of Science ®Google Scholar
• Kelidari HR, Saeedi M, Hajheydari Z, Akbari J, Morteza-Semnani K, Akhtari J, Valizadeh H, Asare-Addo K, Nokhodchi A. 2016. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: a randomized, double-blind, prospective trial. Colloids Surf, B. 146:47–53.
   PubMed Web of Science ®Google Scholar
• Knoke I, Jakubiczka S, Lehnert H, Wieacker P. 1999. A new point mutation of the androgen receptor gene in a patient with partial androgen resistance and severe oligozoospermia. Andrologia. 31(4):199–201.
   PubMed Web of Science ®Google Scholar
• Korhonen M, Niskanen H, Kiesvaara J, Yliruusi J. 2000. Determination of optimal combination of surfactants in creams using rheology measurements. Int J Pharm. 197(1–2):143–151.
   PubMed Web of Science ®Google Scholar
• Loden M. 2003. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 4(11):771–788.
   PubMed Web of Science ®Google Scholar
• Lynde C. 2008. Moisturizers for the treatment of inflammatory skin conditions. J Drugs Dermatol. 7(11):1038–1043.
   PubMedGoogle Scholar
• Malik DS, Kaur G. 2018. Nanostructured gel for topical delivery of azelaic acid: designing, characterization, and in-vitro evaluation. J Drug Deliv Sci Technol. 47:123–136.
   Web of Science ®Google Scholar
• Marson JW, Baldwin HE. 2019. An overview of acne therapy, part 1: topical therapy, oral antibiotics, laser and light therapy, and dietary interventions. Dermatol Clin. 37(2):183–193.
   PubMed Web of Science ®Google Scholar
• Masmoudi H, Dréau YL, Piccerelle P, Kister J. 2005. The evaluation of cosmetic and pharmaceutical emulsions aging process using classical techniques and a new method: FTIR. Int J Pharm. 289(1–2):117–131.
   PubMed Web of Science ®Google Scholar
• Messina M, Manieri C, Rizzi G, Gentile L, Milani P. 1985. Treating acne with antiandrogens: the confirmation of the validity of percutaneous treatment with spironolactone. Curr Therap Res. 38:269–282.
   Web of Science ®Google Scholar
• Nielloud F, Marti-Mestnes G. 2000. Pharmaceutical emulsions and suspensions. New York – Basel: Marcel Dekker, Inc. Chapter 3, Emulsion Properties and Related Know-how to Attain Them; p. 73–125.
   Google Scholar
• Olutunmbi Y, Paley K, English JCII. 2008. Adolescent female acne: etiology and management. J Pediatr Adolesc Gynecol. 21(4):171–176.
   PubMed Web of Science ®Google Scholar
• Oon HH, Wong SN, Aw DCW, Cheong WK, Goh CL, Tan HH. 2019. Acne management guidelines by the dermatological society of Singapore. J Clin Aesthet Dermatol. 12(7):34–50.
   PubMedGoogle Scholar
• Paolino D, Ventura CA, Nistico S, Puglisi G, Fresta M. 2002. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm. 244(1–2):21–31.
   PubMed Web of Science ®Google Scholar
• Ramezanli T, Zhang Z, Michniak-Kohn BB. 2017. Development and characterization of polymeric nanoparticle-based formulation of adapalene for topical acne therapy. Nanomedicine. 13(1):143–152.
   PubMed Web of Science ®Google Scholar
• Ramos-e-Silva M, Ramos-e-Silva S, Carneiro S. 2015. Acne in women. Br J Dermatol. 172(S1):20–26.
   PubMed Web of Science ®Google Scholar
• Rey FO, Valterio C, Locatelli L, Ramelet AA, Felber JP. 1988. Lack of endocrine systemic side effects after topical application of spironolactone in man. J Endocrinol Invest. 11(4):273–278.
   PubMed Web of Science ®Google Scholar
• Rieger MM. 1991. Stability testing of macroemulsions. Cosmet Toilet. 106(5):59–67.
   Google Scholar
• Rogiers V. 2001. EEMCO guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacol Appl Skin Physiol. 14(2):117–128.
   PubMedGoogle Scholar
• Sato K, Matsumoto D, Iizuka F, Aiba-Kojima E, Watanabe-Ono A, Suga H, Inoue K, Gonda K, Yoshimura K. 2006. Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians. Aesthetic Plast Surg. 30(6):689–694.
   PubMed Web of Science ®Google Scholar
• Savic S, Lukic M, Jaksic I, Reichl S, Tamburic S, Müller-Goymann C. 2011. An alkyl polyglucoside-mixed emulsifier as stabilizer of emulsion systems: the influence of colloidal structure on emulsions skin hydration potential. J Colloid Interface Sci. 358(1):182–191.
   PubMed Web of Science ®Google Scholar
• Savic S, Tamburic S, Savic M. 2010. From conventional towards new – natural surfactants in drug delivery systems design: current status and perspectives. Expert Opin Drug Deliv. 7(3):353–369.
   PubMed Web of Science ®Google Scholar
• Savic S, Tamburic S, Savic M, Cekic N, Milic J, Vuleta G. 2004. Vehicle-controlled effect of urea on normal and SLS-irritated skin. Int J Pharm. 271(1–2):269–280.
   PubMed Web of Science ®Google Scholar
• Savic S, Weber C, Savic MM, Müller-Goymann C. 2009. Natural surfactant-based topical vehicles for two model drugs: influence of different lipophilic excipients on in vitro/in vivo skin performance. Int J Pharm. 381(2):220–230.
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Mehnert W, Korting HC. 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 59(6):427–443.
   PubMed Web of Science ®Google Scholar
• Seppic F. Catalog – MontanovTM202, 2001.
   Google Scholar
• Sugarman JH, Fleischer AB, Feldman SR. 2002. Off-label prescribing in the treatment of dermatologic disease. J Am Acad Dermatol. 47(2):217–223.
   PubMed Web of Science ®Google Scholar
• Tamburic S, Craig DQM, Vuleta G, Milic J. 1996. A comparison of electrical and rheological techniques for the characterisation of creams. Int J Pharm. 137(2):243–248.
   Web of Science ®Google Scholar
• Tasic-Kostov M, Arsic I, Pavlovic D, Stojanović S, Najman S, Naumović S, Tadić V. 2019. Towards a modern approach to traditional use: in vitro and in vivo evaluation of Alchemilla vulgaris L. gel wound healing potential. J Ethnopharmacol. 238:111789.
   PubMed Web of Science ®Google Scholar
• Tasic-Kostov M, Reichl S, Lukic M, Jaksic I, Savic S. 2011. Does lactobionic acid affect the colloidal structure and skin moisturizing potential of the alkyl polyglucoside-based emulsion systems? Pharmazie. 66(11):862–870.
   PubMed Web of Science ®Google Scholar
• Tasic-Kostov M, Vesic S, Savic S. 2014. Alkyl polyglucosides: from natural origin surfactants to prospective delivery systems. Oxford: Elsevier Limited. Chapter 6, Objective skin performance evaluation: How mild are APGs to the skin? p. 135–161.
   Google Scholar
• Thiboutot D. 2001. Hormones and acne: pathophysiology, clinical evaluation, and therapies. Semin Cutan Med Surg. 20(3):144–153.
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Del Rosso JQ. 2013. Acne vulgaris and the epidermal barrier: is acne vulgaris associated with inherent epidermal abnormalities that cause impairment of barrier functions? Do any topical acne therapies alter the structural and/or functional integrity of the epidermal barrier? J Clin Aesthet Dermatol. 6(2):18–24.
   PubMedGoogle Scholar
• Uysal G, Sahin Y, Unluhizarci K, Ferahbas A, Uludag SZ, Aygen E, Kelestimur F. 2017. Is acne a sign of androgen excess disorder or not? Eur J Obstet Gynecol Reprod Biol. 211:21–25.
   PubMed Web of Science ®Google Scholar
• Vargas-Mora P, Morgado-Carrasco D. 2020. Spironolactone in dermatology: uses in acne. Actas Dermosifiliogr. 111(8):639–649.
   PubMed Web of Science ®Google Scholar
• von Rybinski W, Hill K. 1998. Alkyl polyglycosides-properties and applications of a new class of surfactants. Angew Chem Int Ed Engl. 37(10):1328–1345.
   PubMed Web of Science ®Google Scholar
• Weltfriend S, Bason M, Lammintausta K, Maibach HI. 1996. Dermatotoxicology (5th ed). Washington, DC: Taylor & Francis. Irritant dermatitis (Irritation); p. 87–118.
   Google Scholar
• Yamamoto A, Ito M. 1996. Topical spironolactone reduces sebum secretion rates in young adults. J Dermatol. 23(4):243–246.
   PubMedGoogle Scholar
• Zugic A, Lunter DJ, Daniels R, Pantelic I, Tasic-Kostov M, Tadic V, Misic D, Arsic I, Savic S. 2016. Usnea barbata CO2-supercritical extract in alkyl polyglucoside-based emulsion system: contribution of Confocal Raman imaging to the formulation development of a natural product. Pharm Dev Technol. 21(5):563–575.
   PubMed Web of Science ®Google Scholar